Creo Medical Limited
CREO.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £71 | £144 | £47 | £254 |
| - Cash | £9 | £3 | £13 | £44 |
| + Debt | £4 | £8 | £12 | £11 |
| Enterprise Value | £66 | £149 | £46 | £221 |
| Revenue | £4 | £31 | £27 | £25 |
| % Growth | -87% | 13.4% | 8% | – |
| Gross Profit | £2 | £15 | £10 | £9 |
| % Margin | 47.5% | 49.7% | 36.8% | 35.9% |
| EBITDA | -£26 | -£21 | -£28 | -£28 |
| % Margin | -652.5% | -67.2% | -101.6% | -109.5% |
| Net Income | -£29 | -£22 | -£27 | -£25 |
| % Margin | -717.5% | -70.5% | -99.1% | -97.8% |
| EPS Diluted | -0.079 | -0.069 | -0.14 | -0.14 |
| % Growth | -14.6% | 50.5% | 0% | – |
| Operating Cash Flow | -£22 | -£22 | -£25 | -£26 |
| Capital Expenditures | -£0 | -£1 | -£3 | -£6 |
| Free Cash Flow | -£23 | -£23 | -£28 | -£32 |